Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OO-13003851Phase 4Completed
Phase 4, open-label, single-arm trial of etomidate in None, sponsored by Peking University Third Hospital. Primary endpoints: Plasma concentration of drug and Bispectral Index. Started Jun 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OO-13003851.